Randomized controlled trial of a mobile phone intervention for improving adherence to naltrexone for alcohol use disorders

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Stoner, Susan A ^a   Arenella, Pamela B ^b   Hendershot, Christian S ^c,d,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Lovelace Biomedical and Environmental Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; NARCOTIC ANTAGONIST;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ANXIETY; ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MOBILE PHONE; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TEXT MESSAGING; THIRST; WEAKNESS; WITHDRAWAL SYNDROME; ALCOHOL-RELATED DISORDERS; HEALTH SURVEY; MIDDLE AGED; MORTALITY; QUESTIONNAIRE; RISK FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ALCOHOL-RELATED DISORDERS; CELL PHONES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TEXT MESSAGING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928896622     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124613     Document Type: Article

References (39)

1. Swift R, Oslin DW, Alexander M, Forman R. Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs 2011; 72: 1012-8. PMID: 22051215
2. Reid SC, Teesson M, Sannibale C, Matsuda M, Haber PS. The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial. J Stud Alcohol 2005; 66: 833-41. PMID: 16459945
3. Pettinati HM, Weiss RD, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. COMBINE Monograph Series, Volume 2. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. DHHS Publication No. (NIH) 04-5289. Bethesda, MD: NIAAA; 2004. doi: 10.1001/jama.2014.15939 PMID: 25585329
4. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006; 295: 2003-17. PMID: 16670409
5. Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol 2006; 26: 610-25. PMID: 17110818
6. Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2010: CD001867.
7. Mark TL, Kranzler HR, Song X, Bransberger P, Poole VH, Crosse S. Physicians' opinions about medications to treat alcoholism. Addiction 2003; 98: 617-26. PMID: 12751979
8. Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, et al. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res 2001; 25: 1634-47. PMID: 11707638
9. Kranzler HR. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol 2000; 35: 537-47. PMID: 11093959
10. Pettinati HM, Volpicelli JR, Pierce JD Jr, O'Brien CP. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis 2000; 19: 71-83. PMID: 11076121
11. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP. Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry 1997; 54: 737-42. PMID: 9283509
12. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 2000; 35: 587-93. PMID: 11093966
13. Baros AM, Latham PK, Moak DH, Voronin K, Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res 2007; 31: 596-603. PMID: 17374038
14. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003; 6: 566-73. PMID: 14627063
15. Oslin DW, Lynch KG, Pettinati HM, Kampman KM, Gariti P, Gelfand L, et al. A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res 2008; 32: 1299-308. doi: 10.1111/j.1530-0277.2008.00698.x PMID: 18540910
16. Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, et al. Relationship between medication adherence and treatment outcomes: the COMBINE study. Alcohol Clin Exp Res 2008; 32: 1661-9. doi: 10.1111/j.1530-0277.2008.00743.x PMID: 18616687
17. Rohsenow DJ, Colby SM, Monti PM, Swift RM, Martin RA, Mueller TI, et al. Predictors of compliance with naltrexone among alcoholics. Alcohol Clin Exp Res 2000; 24: 1542-9. PMID: 11045863
18. Anton RF. Naltrexone for the management of alcohol dependence. N Engl J Med 2008; 359: 715-21. doi: 10.1056/NEJMct0801733 PMID: 18703474
19. Kranzler HR, Modesto-Lowe V, Van Kirk J. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology 2000; 22: 493-503. PMID: 10731624
20. Simoni JM, Huh D, Frick PA, Pearson CR, Andrasik MP, Dunbar PJ, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr 2009; 52: 465-73. PMID: 19911481
21. Brown ES, Carmody TJ, Schmitz JM, Caetano R, Adinoff B, Swann AC, et al. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 2009; 33: 1863-9. doi: 10.1111/j.1530-0277.2009.01024.x PMID: 19673746
22. Pettinati HM, Weiss RD, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. COMBINE Monograph Series, Volume 2. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. DHHS Publication No. (NIH) 04-5289. Bethesda, MD: NIAAA; 2004. doi: 10.1001/jama.2014.15939 PMID: 25585329
23. Volpicelli JR, Pettinati HM, McLellan AT, O'Brien CP. Combining medication and psychosocial treatments for addictions: The BRENDA approach. New York: Guilford Press; 2001.
24. Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, et al. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res 2004; 28: 1710-7. PMID: 15547458
25. Gurvich EM, Kenna GA, Leggio L. Use of Novel Technology-Based Techniques to Improve Alcohol-Related Outcomes in Clinical Trials. Alcohol Alcohol 2013.
26. Linn AJ, Vervloet M, van Dijk L, Smit EG, Van Weert JC. Effects of eHealth interventions on medication adherence: a systematic review of the literature. J Med Internet Res 2011; 13: e103. doi: 10.2196/jmir.1738 PMID: 22138112
27. Dimeff LA, Paves AP, Skutch JM, Woodcock EA. Shifting paradigms in clinical psychology: How innovative technologies are shaping treatment delivery. In: Barlow DH, editor. The Oxford Handbook of Clinical Psychology. New York: Oxford University Press; 2010. p. 618-48.
28. Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol 2010; 15: 1-39. doi: 10.1348/135910709X466063 PMID: 19646331
29. Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving Adherence to Antiretroviral Therapy for Youth Living with HIV/AIDS: A Pilot Study Using Personalized, Interactive, Daily Text Message Reminders. J Med Internet Res 2012; 14: e51. doi: 10.2196/jmir.2015 PMID: 22481246
30. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010; 376: 1838-45. doi: 10.1016/S0140-6736(10)61997-6 PMID: 21071074
31. Stoner SA, Hendershot CS. A randomized trial evaluating an mHealth system to monitor and enhance adherence to pharmacotherapy for alcohol use disorders. Addict Sci Clin Pract 2012; 7: 9. doi: 10.1186/1940-0640-7-9 PMID: 23186301
32. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
33. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption - II. Addiction 1993; 88: 791-804. PMID: 8329970
34. Skinner HA, Allen BA. Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 1982; 91: 199-209. PMID: 7096790
35. Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 1999; 23: 1289-95. PMID: 10470970
36. Sobell LC, Sobell MB. Timeline Followback: A technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, editors. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; 1992. p. 41-72.
37. Faul F, Erdfelder E, Buchner A, Lang A-G. G∗Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007; 39: 175-91. PMID: 17695343
38. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009; 41: 1149-60. doi: 10.3758/BRM.41.4.1149 PMID: 19897823
39. Rainie L. Internet, broadband, and cell phone statistics. Washington, DC: Pew Internet & American Life Project; 2009 [updated January 5, 2010; cited 2013 September 16, 2013]; Available: http://www.pewinternet.org/~/media//Files/Reports/2010/PIP-December09-update.pdf.